EyeYon Medical pioneers advanced ophthalmic devices, including EndoArt®, the first synthetic implant for corneal edema, offering a groundbreaking alternative to traditional corneal transplants.
At EyeYon Medical, we are committed to revolutionising the treatment of corneal edema by providing innovative, sight-saving solutions. Our vision is to offer hope to patients who are unsuitable for human tissue transplants, while also establishing a new standard of care through EndoArt® - a synthetic and scalable alternative to traditional corneal transplantation. By expanding the options available to both patients and surgeons, we aim to improve vision and quality of life for patients around the world.
The Future
of Corneal Transplants
EndoArt® is the first synthetic implant to treat corneal edema and save vision. We are breaking the barriers for corneas availability, the most common organ transplant worldwide.
“If you don’t have donor tissue, the EndoArt is the finding of the century”
“EndoArt under promised and over delivered”
“EndoArt is easier than doing DSAEK or DMEK”
The introduction of EndoArt, which serves as an artificial layer reducing the fluid transfer from the aqueous to the corneal stroma, is a huge step forward.
The EndoArt® is a critical step forward as the ideal solution for the problem of corneal failure as an “on the shelf” solution for almost every ophthalmic surgeon, not only corneal specialist.
The EndoArt could provide a paradigm shift in the treatment of patients with endothelial failure while eliminating the need for human donor tissue.
I’m grateful…to take first steps towards eliminating the global shortage of corneal tissue